1. Home
  2. CSL vs MEDP Comparison

CSL vs MEDP Comparison

Compare CSL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$326.60

Market Cap

13.4B

Sector

Industrials

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$604.14

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSL
MEDP
Founded
1917
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
16.1B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
CSL
MEDP
Price
$326.60
$604.14
Analyst Decision
Buy
Hold
Analyst Count
6
12
Target Price
$386.67
$479.64
AVG Volume (30 Days)
402.7K
203.1K
Earning Date
02-03-2026
02-09-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
25.36
EPS
17.56
14.32
Revenue
$5,015,100,000.00
$2,358,373,000.00
Revenue This Year
$1.01
$21.43
Revenue Next Year
$2.69
$11.99
P/E Ratio
$19.13
$42.52
Revenue Growth
0.14
13.88
52 Week Low
$293.43
$250.05
52 Week High
$435.92
$626.26

Technical Indicators

Market Signals
Indicator
CSL
MEDP
Relative Strength Index (RSI) 49.48 66.05
Support Level $318.99 $551.00
Resistance Level $333.87 $577.40
Average True Range (ATR) 8.67 13.54
MACD -0.18 4.98
Stochastic Oscillator 31.49 85.51

Price Performance

Historical Comparison
CSL
MEDP

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: